Now accepting Telehealth appointments. Schedule a virtual visit.

CHR's COVID-19 Bulletin, May 22, 2020

CHR's COVID-19 Bulletin, May 22, 2020

CHR tries to combat misinformation about COVID-19 through these periodic COVID-19 Bulletins. Image by United Nations COVID-19 Response via Unsplash.

[This article deals with an evolving situation with many unknowns. It was written by Norbert Gleicher, MD, on May 21, 2020 and published on May 22, 2020. For a list of all COVID-19 Bulletins, scroll to the bottom.]

Though much still remains to be leared about COVID-19, clarity is starting to break through the clouds on a number of important issues. We here do not intend to repeat in detail what media are reporting on a daily basis but want to, with bullet points, simply summarize some of the conclusions that are becoming increasingly obvious but are not always reported by the media.

Mortality

Antibodies and Viral Mutation

Risk Groups

Mitigation Strategies

Pregnancy and Reproduction

In summary, the reopening of the U.S. economy appears overdue. This does not mean unrestricted reopening and abandonment of all quarantine measures but “guided” reopening, almost unrestricted for low-risk individuals and increasingly restricted with increasing risk status. Interested readers are also referred to CHR’s upcoming monthy newsletter for June, the CHR VOICE, where an article will address what it means “to follow science,” when combating the COVID-19 virus.

CHR's COVID-19 Bulletins

Norbert Gleicher, MD

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

 


We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS

 

You Might Also Enjoy...

The March/April Voice

Every issue of the VOICE slowly drifts towards more professional subjects, peaking with the literature review, which, primarily addresses physicians and scientists.
IVF in Alabama - What To Do Next?

IVF in Alabama - What To Do Next?

CHR offers the safe transfer of existing frozen embryos into our facility, ensuring continuity of care for patients affected by the suspension of IVF services in Alabama.

Should I Get an AMH Test?

Testing your anti-Mullerian hormone (AMH) levels can provide a lot of information about your ovarian reserve. Find out if you’d be a good candidate for an AMH test here.